ScreenCell will take part in the 27th edition of SIMEM 2025 alongside Genethical®, our exclusive partner in Algeria. This major event in the North African medical sector will be held from April 9 to 12, 2025, in Oran.
A technology for precision oncology – Booth Z 35-36
During your visit to the SIMEM 2025, be sure to stop by Booth Z 35-36, where the ScreenCell team will be welcoming you alongside Genethical®.
As the first official distributor of our devices in Algeria, Genethical® plays a key role in the Algerian medical oncology landscape. Today, it is the only Algerian institution offering circulating tumor cell (CTC) analysis—an innovative approach that is transforming cancer monitoring and the early detection of relapse.
This exclusive expertise gives Algerian oncologists and healthcare professionals access to cutting-edge methods for more effective, personalized medicine that is also more affordable for patients.
Our demonstration schedule at SIMEM 2025
Genethical®: A Partner of Excellence for Precision Medicine
Founded in 2020, the Genethical® Laboratory quickly established itself as a leader in molecular biology in Algeria. Aligning with the national vision of combating cancer through early detection, this reference laboratory aims to improve therapeutic pathways in oncology through high-precision analyses.
Through its partnership with ScreenCell, Genethical® integrates international advances in liquid biopsy, allowing Algerian oncologists to access crucial predictive biomarkers such as circulating tumor cells (CTCs) to optimize patient care.
